Cargando…

Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple Myeloma

INTRODUCTION: Ciltacabtagene autoleucel (cilta-cel), is a B-cell maturation antigen-directed, genetically modified autologous chimeric antigen receptor T-cell (CAR-T) immunotherapy. It is indicated for treatment for adult patients with relapsed or refractory multiple myeloma (RRMM) after four or mor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jagannath, Sundar, Joseph, Nedra, Crivera, Concetta, Kharat, Akshay, Jackson, Carolyn C., Valluri, Satish, Cost, Patricia, Phelps, Hilary, Slowik, Rafal, Klein, Timothy, Smolen, Lee, Yu, Xueting, Cohen, Adam D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260711/ https://www.ncbi.nlm.nih.gov/pubmed/37014590 http://dx.doi.org/10.1007/s40487-023-00228-5

Ejemplares similares

Healthcare Costs Incurred by Patients with Multiple Myeloma Following Triple Class Exposure (TCE) in the US
por: Jagannath, Sundar, et al.
Publicado: (2021)

Healthcare Costs of Multiple Myeloma Patients with Four or More Prior Lines of Therapy, Including Triple-Class Exposure in the United States
por: Jagannath, Sundar, et al.
Publicado: (2022)

Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple Myeloma
por: Palmer, Stephen, et al.
Publicado: (2023)

Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE‐1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma
por: Martin, Thomas, et al.
Publicado: (2021)

The Cost of Car Upkeep
Publicado: (1909)

Applying State-of-the-Art Survival Extrapolation Techniques to the Evaluation of CAR-T Therapies: Evidence from a Systematic Literature Review
por: Sussman, Matthew, et al.
Publicado: (2021)

Estimating the Economic Impact of Adding Panobinostat to a U.S. Formulary for Relapsed and/or Refractory Multiple Myeloma: A Budget Impact and Cost-Benefit Model
por: Bloudek, Lisa, et al.
Publicado: (2016)

Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions
por: Margolis, Jay M., et al.
Publicado: (2016)

Cost-Effectiveness Analysis of CAR T-Cell Therapies vs Antibody Drug Conjugates for Patients with Advanced Multiple Myeloma
por: Kapinos, Kandice A., et al.
Publicado: (2023)

Recent progress in the treatment of multiple myeloma: updates and highlights from ASH 2008
por: Jagannath, Sundar
Publicado: (2009)

The Annual Cost of a Doctor's Motor-Car
Publicado: (1911)

Conjugation dynamics depend on both the plasmid acquisition cost and the fitness cost
por: Prensky, Hannah, et al.
Publicado: (2021)

Drug utilization and cost in a Medicaid population: A simulation study of community vs. mail order pharmacy
por: Valluri, Satish, et al.
Publicado: (2007)

Proteasome inhibition and its therapeutic potential in multiple myeloma
por: Chari, Ajai, et al.
Publicado: (2010)

Overhauling CAR T Cells to Improve Efficacy, Safety and Cost
por: Chicaybam, Leonardo, et al.
Publicado: (2020)

Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies
por: Cohen, Adam D., et al.
Publicado: (2022)

The Evaluation of Clinical and Cost Outcomes Associated with Earlier Initiation of Insulin in Patients with Type 2 Diabetes Mellitus
por: Smolen, Harry J., et al.
Publicado: (2014)

Recent Advances in the Understanding and Treatment of Multiple Myeloma
por: Cook, Richard, et al.
Publicado: (2008)

CAR T cell therapy: newer approaches to counter resistance and cost
por: Yadav, Rajesh Kumar, et al.
Publicado: (2020)

Improved Resolution and Cost Performance of Low-Cost MEMS Seismic Sensor through Parallel Acquisition
por: Hu, Xing-Xing, et al.
Publicado: (2021)

Cost structure effects of horizontal airline mergers and acquisitions
por: Gudmundsson, Sveinn Vidar, et al.
Publicado: (2020)

A Low-Cost Multi-Sensor Data Acquisition System for Fault Detection in Fused Deposition Modelling
por: Kumar, Satish, et al.
Publicado: (2022)

Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
por: Laliberté, François, et al.
Publicado: (2015)

Unintended Consequences of Increased Out-of-Pocket Costs During Medicare Coverage Gap on Anticoagulant Discontinuation and Stroke
por: Salam, Tabassum, et al.
Publicado: (2023)

Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
por: Laliberté, François, et al.
Publicado: (2015)

Medical Costs Associated with Use of Systemic Therapy in Adults with Colorectal Cancer
por: Seal, Brian S., et al.
Publicado: (2013)

Understanding the Competitive Advantages of Car Sharing from the Travel-Cost Perspective
por: Dong, Xianlei, et al.
Publicado: (2020)

Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness
por: Neves, Manuel, et al.
Publicado: (2021)

Variable Cultural Acquisition Costs Constrain Cumulative Cultural Evolution
por: Mesoudi, Alex
Publicado: (2011)

A low-cost IoT multi-spectral acquisition device
por: Botero-Valencia, J.S., et al.
Publicado: (2021)

Modeling Global Carbon Costs of Plant Nitrogen and Phosphorus Acquisition
por: Braghiere, R. K., et al.
Publicado: (2022)

Low cost and easy acquisition: corn grain in microsurgery training
por: FERNANDES, MANUELA RODRIGUES NEIVA, et al.
Publicado: (2022)

European Myeloma Network perspective on CAR T-cell therapies for multiple myeloma
por: Bruno, Benedetto, et al.
Publicado: (2021)

The outcomes of newly diagnosed elderly multiple myeloma patients treated at a single U.S. institution
por: Bonomo, Lauren, et al.
Publicado: (2016)

Effectiveness, safety, and healthcare costs associated with rivaroxaban versus warfarin among venous thromboembolism patients with obesity: a real-world study in the United States
por: Berger, Jeffrey S., et al.
Publicado: (2022)

CAR-T cell therapy in myeloma: hopes and hurdles
por: Harousseau, Jean Luc
Publicado: (2023)

Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report
por: Madduri, D., et al.
Publicado: (2021)

Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of the CARS Study
por: Strilciuc, Stefan, et al.
Publicado: (2023)

Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation
por: Elnaggar, Muhammad, et al.
Publicado: (2022)

Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician’s Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
por: Weisel, Katja, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_12svj6k7fodja8247p6c2smtdn